Difference between revisions of "Emerging Science and Bioethics Advisory Committee"
(→People) |
|||
| Line 10: | Line 10: | ||
*Dr Paula Boddington (Somerville College, University of Oxford) | *Dr Paula Boddington (Somerville College, University of Oxford) | ||
*Ms Madeleine Colvin (Associate Tenant at Doughty Street Chambers) | *Ms Madeleine Colvin (Associate Tenant at Doughty Street Chambers) | ||
| − | *Professor Bobbie Farsides(Brighton and Sussex Medical School) | + | *Professor Bobbie Farsides (Brighton and Sussex Medical School) |
*Mr [[Julian Hitchcock]] (Life Science Legal Practice, [[Lawford Davies Denoon]]) | *Mr [[Julian Hitchcock]] (Life Science Legal Practice, [[Lawford Davies Denoon]]) | ||
*Dr Stuart Hogarth (Department of Social Science, Health and Medicine, King’s College London) | *Dr Stuart Hogarth (Department of Social Science, Health and Medicine, King’s College London) | ||
Revision as of 22:26, 27 November 2012
The Emerging Science and Bioethics Advisory Committee (ESBAC) was set up in 2012[1] to replace the Human Genetics Commission, which was closed down following the UK government's review of Arm's Length Bodies.[2] According to an article for BioNews, "While ESBAC will take on the responsibilities of the HGC, it also has a broader remit than human genetics."[3]
The UK government Department of Health's website stated, "The committee will be responsible for providing advice to UK Health Departments on emerging healthcare scientific developments and their ethical, legal, social and economic implications."[4]
Contents
People
Committee members (as from June 2012) are:[5]
- Professor Sir Alasdair Breckenridge, Chair
- Dr Dipti Amin (Quintiles)
- Professor Andrew Baker (Institute of Cardiovascular and Medical Sciences, University of Glasgow)
- Dr Paula Boddington (Somerville College, University of Oxford)
- Ms Madeleine Colvin (Associate Tenant at Doughty Street Chambers)
- Professor Bobbie Farsides (Brighton and Sussex Medical School)
- Mr Julian Hitchcock (Life Science Legal Practice, Lawford Davies Denoon)
- Dr Stuart Hogarth (Department of Social Science, Health and Medicine, King’s College London)
- Professor Nicholas Lemoine (Barts Cancer Institute)
- Professor Peter Littlejohns (Department of Primary Care and Public Health Sciences, King’s College London)
- Professor Duncan McHale (UCB)
- Dr Jonathan Mill (Institute of Psychiatry, King’s College London and the University of Exeter)
- Mr James Peach (Cancer Research UK)
- Dr Neil James Scolding (University of Bristol and Frenchay Hospital Bristol)
- Dr Bella Starling (Nowgen)
- Professor Joyce Tait (Economic and Social Research Innogen Centre, University of Edinburgh)
- Mr David Townend (Faculty of Health, Medicine and Life Sciences, Maastricht University)
In addition, the following members were nominated by their organisations as ex-officio members:
- Dr John Brown (Technology Strategy Board)
- Professor Angus Clarke (Wales Chief Medical Officer Representative)
- Ms Katherine Littler (Wellcome Trust)
- Dr Julie Maxton (The Royal Society)
- Dr Michael McBride (Northern Ireland Chief Medical Officer)
- Professor Andrew Morris (Scotland Chief Medical Officer Representative)
- Dr Rachel Quinn (Academy of Medical Sciences)
- Professor Sir John Savill (Medical Research Council)
- Ms Diana Sternfeld (BioIndustry Association)
- Mr Stephen Whitehead (Association of the British Pharmaceutical Industry)
- Mr Hugh Whittall (Nuffield Council on Bioethics)
Funding
Contact
- Address:
- ...
- ...
- ...
- ...
- Phone:
- ...
- Email:
- ...
- Website:
- ...
Resources
Notes
- ↑ Rebecca Hill (2012), Human Genetics Commission publish final report, 7 Jun, acc 27 Nov 2012
- ↑ HGC (2012) Home, acc 27 Nov 2012
- ↑ Rebecca Hill (2012), Human Genetics Commission publish final report, 7 Jun, acc 27 Nov 2012
- ↑ Members of Emerging Science and Bioethics Advisory Committee confirmed, 20 Jun 2012, acc 27 Nov 2012
- ↑ Members of Emerging Science and Bioethics Advisory Committee confirmed, 20 Jun 2012, acc 27 Nov 2012
